Literature DB >> 22415357

Correlation between oocyte number and follicular fluid concentration of pituitary adenylate cyclase-activating polypeptide (PACAP) in women after superovulation treatment.

M Koppan1, A Varnagy, D Reglodi, R Brubel, J Nemeth, A Tamas, L Mark, J Bodis.   

Abstract

Follicular growth, ovulation, and luteinization are influenced by interactions of peptide and steroid hormone-signaling cascades in the ovary. Pituitary adenylate cyclase-activating polypeptide (PACAP) plays an important role in the regulation of several endocrine processes and is present in ovarian follicular fluid (FF). However, little is known about PACAP in FF with regard to maturation, ovulation, fertilization, and successful pregnancy. The aim of this pilot study was to investigate whether there is a correlation between PACAP concentration in FF and ovarian response to superovulation treatment in infertile women, performed in volunteers (n = 132; aged between 20 and 35). After treatment, the number of harvested oocytes was recorded and PACAP immunoreactivity in FF was measured by radioimmunoassay. All the corresponding PACAP concentrations were below 290 fmol/ml in cases when the number of harvested oocytes exceeded 14 per patient, while in all cases above 290 fmol/ml, the number of oocytes was below 14. Using these cutoff values, we determined three study groups: high-PACAP concentration, high-oocyte number, and low-PACAP concentration-low-oocyte number groups. Median values of PACAP concentration in these groups were 411.2, 106.5, and 101.0 fmol/ml, respectively, while the median values of harvested oocytes were 5.5, 19.0, and 5.0, respectively. Differences were significant, indicating a correlation between concentration of PACAP in FF and the number of recruited oocytes. Higher concentrations of PACAP in FF might be associated with lower number of developing oocytes, while low concentrations of PACAP might correlate with a markedly higher number of ova retrieved, thus predicting a higher chance for ovarian hyperstimulation. Our present study is among the first few human clinical studies with direct conclusions drawn for possible clinical impact of PACAP.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22415357     DOI: 10.1007/s12031-012-9743-3

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  36 in total

1.  Characterization and expression of different pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptors in rat ovarian follicles.

Authors:  Sergio Vaccari; Stefania Latini; Marzia Barberi; Anna Teti; Mario Stefanini; Rita Canipari
Journal:  J Endocrinol       Date:  2006-10       Impact factor: 4.286

2.  Transient periovulatory expression of pituitary adenylate cyclase activating peptide in rat ovarian cells.

Authors:  S Gräs; J Hannibal; B Georg; J Fahrenkrug
Journal:  Endocrinology       Date:  1996-11       Impact factor: 4.736

3.  PAC1 receptors mediate pituitary adenylate cyclase-activating polypeptide- and progesterone-facilitated receptivity in female rats.

Authors:  Ede Marie Apostolakis; Deanna N Riherd; Bert W O'Malley
Journal:  Mol Endocrinol       Date:  2005-06-23

4.  Gonadotropin-dependent regulation of bovine pituitary adenylate cyclase-activating polypeptide in ovarian follicles prior to ovulation.

Authors:  Khampoune Sayasith; Kristy A Brown; Jean Sirois
Journal:  Reproduction       Date:  2007-02       Impact factor: 3.906

5.  Pituitary adenylate cyclase-activating polypeptide modulates plasminogen activator expression in rat granulosa cell.

Authors:  Rosanna Apa; Antonio Lanzone; Fiorella Miceli; Sergio Vaccari; Elisabetta Macchione; Mario Stefanini; Rita Canipari
Journal:  Biol Reprod       Date:  2002-03       Impact factor: 4.285

6.  Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor.

Authors:  Kerry J Ressler; Kristina B Mercer; Bekh Bradley; Tanja Jovanovic; Amy Mahan; Kimberly Kerley; Seth D Norrholm; Varun Kilaru; Alicia K Smith; Amanda J Myers; Manuel Ramirez; Anzhelika Engel; Sayamwong E Hammack; Donna Toufexis; Karen M Braas; Elisabeth B Binder; Victor May
Journal:  Nature       Date:  2011-02-24       Impact factor: 49.962

7.  Presence of pituitary adenylate cyclase activating polypeptide-38 in human plasma and milk.

Authors:  Rita Borzsei; Laszlo Mark; Andrea Tamas; Terez Bagoly; Csaba Bay; Katalin Csanaky; Eszter Banki; Peter Kiss; Alexandra Vaczy; Gabriella Horvath; Jozsef Nemeth; Edit Szauer; Zsuzsanna Helyes; Dora Reglodi
Journal:  Eur J Endocrinol       Date:  2009-01-27       Impact factor: 6.664

8.  Serotonin may alter the pattern of gonadotropin-induced progesterone release of human granulosa cells in superfusion system.

Authors:  Miklos Koppan; Jozsef Bodis; Zsofia Verzar; Hans-Rudolf Tinneberg; Attila Torok
Journal:  Endocrine       Date:  2004-07       Impact factor: 3.633

9.  The effect of catecholamines, acetylcholine and histamine on progesterone release by human granulosa cells in a granulosa cell superfusion system.

Authors:  J Bódis; M Koppán; L Kornya; H R Tinneberg; A Török
Journal:  Gynecol Endocrinol       Date:  2002-08       Impact factor: 2.260

10.  The role of PACAP in gonadotropic hormone secretion at hypothalamic and pituitary levels.

Authors:  Katalin Köves; Orsolya Kántor; Judith Molnár; Andrea Heinzlmann; Enikö Szabó; Flóra Szabó; Agnes Nemeskéri; Judit Horváth; Akira Arimura
Journal:  J Mol Neurosci       Date:  2003-04       Impact factor: 3.444

View more
  10 in total

1.  PACAP immunoreactivity in human malignant tumor samples and cardiac diseases.

Authors:  Z Szanto; Zs Sarszegi; D Reglodi; J Nemeth; K Szabadfi; P Kiss; A Varga; E Banki; K Csanaky; B Gaszner; O Pinter; Zs Szalai; A Tamas
Journal:  J Mol Neurosci       Date:  2012-05-31       Impact factor: 3.444

2.  Changes in PACAP immunoreactivity in human milk and presence of PAC1 receptor in mammary gland during lactation.

Authors:  Katalin Csanaky; Eszter Banki; Krisztina Szabadfi; Dora Reglodi; Ibolya Tarcai; Levente Czegledi; Zsuzsanna Helyes; Tibor Ertl; Judit Gyarmati; Zalan Szanto; Istvan Zapf; Erika Sipos; Seiji Shioda; Andrea Tamas
Journal:  J Mol Neurosci       Date:  2012-04-27       Impact factor: 3.444

3.  Effects of pituitary adenylate cyclase activating polypeptide on human sperm motility.

Authors:  R Brubel; P Kiss; A Vincze; A Varga; A Varnagy; J Bodis; L Mark; E Jambor; G Maasz; H Hashimoto; Zs Helyes; G Toth; A Tamas; M Koppan; D Reglodi
Journal:  J Mol Neurosci       Date:  2012-05-26       Impact factor: 3.444

4.  Influence of terminal differentiation and PACAP on the cytokine, chemokine, and growth factor secretion of mammary epithelial cells.

Authors:  Katalin Csanaky; Wolfgang Doppler; Andrea Tamas; Krisztina Kovacs; Gabor Toth; Dora Reglodi
Journal:  J Mol Neurosci       Date:  2013-12-10       Impact factor: 3.444

5.  Molecular mechanisms underlying the Nephroprotective effects of PACAP in diabetes.

Authors:  Eszter Banki; Krisztina Kovacs; Daniel Nagy; Tamas Juhasz; Peter Degrell; Katalin Csanaky; Peter Kiss; Gabor Jancso; Gabor Toth; Andrea Tamas; Dora Reglodi
Journal:  J Mol Neurosci       Date:  2014-02-19       Impact factor: 3.444

Review 6.  The Neuroprotective and Biomarker Potential of PACAP in Human Traumatic Brain Injury.

Authors:  Denes Toth; Andrea Tamas; Dora Reglodi
Journal:  Int J Mol Sci       Date:  2020-01-28       Impact factor: 5.923

Review 7.  Female reproductive functions of the neuropeptide PACAP.

Authors:  Miklos Koppan; Zsuzsanna Nagy; Inez Bosnyak; Dora Reglodi
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-20       Impact factor: 6.055

8.  Role of PACAP in Female Fertility and Reproduction at Gonadal Level - Recent Advances.

Authors:  Dora Reglodi; Andrea Tamas; Miklos Koppan; Donat Szogyi; Laura Welke
Journal:  Front Endocrinol (Lausanne)       Date:  2012-12-11       Impact factor: 5.555

9.  Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) Pathway Is Induced by Mechanical Load and Reduces the Activity of Hedgehog Signaling in Chondrogenic Micromass Cell Cultures.

Authors:  Tamás Juhász; Eszter Szentléleky; Csilla Szűcs Somogyi; Roland Takács; Nóra Dobrosi; Máté Engler; Andrea Tamás; Dóra Reglődi; Róza Zákány
Journal:  Int J Mol Sci       Date:  2015-07-29       Impact factor: 5.923

Review 10.  Protective Effects of PACAP in Peripheral Organs.

Authors:  Denes Toth; Edina Szabo; Andrea Tamas; Tamas Juhasz; Gabriella Horvath; Eszter Fabian; Balazs Opper; Dora Szabo; Grazia Maugeri; Agata G D'Amico; Velia D'Agata; Viktoria Vicena; Dora Reglodi
Journal:  Front Endocrinol (Lausanne)       Date:  2020-07-14       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.